Podcasts about outpatient

In this episode, Alan Condon, Editor-in-Chief at Becker's Healthcare, discusses major hospital acquisition trends, the financial pressures shaping health systems, and why organizations are accelerating investments in outpatient care and strategic growth.

Learn about the flexible middle ground between weekly therapy and hospitalization. We explore how Intensive Outpatient Programs help working professionals and parents manage depression and anxiety without disrupting their lives - and how to know when you're ready to step down. Read more at https://missionconnectionhealthcare.com/locations/virginia/arlington/ Mission Connection City: San Juan Capistrano Address: 30310 Rancho Viejo Rd. Website: https://missionconnectionhealthcare.com/

Intensive outpatient programs and step-down care are changing how teen self-harm is treated. This episode covers warning signs parents should watch for, evidence-based therapies that work, and why acting early can be life-saving. To learn more, visit https://teencenter.org/teen-iop-yuba-city California Teen Center City: Yuba City Address: 1002 Live Oak Blvd. Website: https://teencenter.org Phone: +1 530 531 8754

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

In this episode, Meredith Warf, CPA DPT, Former Chief Executive Officer, discusses how healthcare leaders can evaluate new technologies by balancing clinical value, financial sustainability, and patient outcomes. She also shares insights on AI, robotics, revenue cycle innovation, and the future of spine and orthopedic care in the outpatient setting.

Send us Fan MailDeliver at 11 PM Tuesday and round at 1 AM Wednesday: paid. Deliver at 8 AM Tuesday and round at 4 PM Tuesday: included in the delivery code, and billing it separately is a compliance violation. Same clinical work, two different outcomes. The only variable is the calendar. Starting January 1, 2027 postpartum care moves to E/M billing with hospital rounds, discharge management, and outpatient checkups all individually billable. Dr. Heather Signorelli walks through the code sets, the same-day trap, the multi-provider wrinkle, and the three-step workflow that catches it every time. The end of the postpartum bundle: Code 59430 (postpartum care only) is deleted January 1, 2027. All postpartum care moves to E/M billing. Two settings, two code sets: inpatient (hospital rounds) and outpatient (office visits). Inpatient postpartum codes: Subsequent hospital care: 99231, 99232, 99233 for daily rounding visits after the date of delivery. Discharge day management: 99238 (30 minutes or less) or 99239 (over 30 minutes). Every rounding day after delivery, on a new calendar date, is a separately billable E/M encounter. Documentation has to support the level. A one-liner does not support a 99233. Outpatient postpartum codes (with telehealth correction): Standard office E/M: 99212 through 99215 with modifier TH. Telehealth uses the same 99212 through 99215 codes with modifier 95 or GT, and place of service 02 or 10. There is no separate “98000” telehealth code set, contrary to earlier references in this series. Modifier TH on all postpartum E/M codes communicates the maternity context to the payer. The same-day rule: Postpartum E/M codes CANNOT be reported on the same calendar date as the delivery code. Same-day postpartum management is included in the delivery code. Calendar date means midnight to midnight, not twenty-four hours from delivery time. The multi-provider wrinkle: If Dr. Smith delivers at 8 AM and Dr. Jones rounds at 4 PM the same day, Dr. Jones cannot bill an E/M for that visit. The delivery code covers same-day postpartum regardless of which provider from the same group performs it. This requires an internal compensation and attribution policy, not just a billing rule. The workflow fix — three steps: Timestamp discipline on every delivery and rounding note Billing team hard stop: verify delivery date before dropping any postpartum E/M charge Daily L and D reconciliation: track delivery date, rounding date, and provider by patient, daily The revenue opportunity: Every hospital rounding day after the delivery date is a new billable E/M. Extended stays from complications (postpartum hemorrhage, severe preeclampsia, wound infection, NICU situations) all generate additional charges. Complexity matters for reimbursement. Outpatient two-week and six-week checks are now individually billable instead of absorbed into a global fee. The same-day rule is the risk. Everything after midnight is the opportunity. Quick Reference Table:Topic                                                                             What to knowDeleted postpartum code                            59430 — deleted Jan 1, 2027 Inpatient rounds                                             99231 – 99233 Discharge codes                                                      99238 (≤30 min) · 99239 (>30 min)Outpatient postpartum                                 99212 – 99215 + modifier TH Telehealth modifier                                        Modifier 95 or GT · POS 02 or 10                                                                             NOT a separate 98000     code set Same-day rule                                                           Postpartum E/M cannot be billed on the                                                                              same calendar date as the delivery Calendar definition                                        Midnight to midnight Multi-provider same-day                                    Delivery code covers regardless of                                                                                       which group provider roundsWorkflow fix                                                    Timestamps · billing hard stop · daily                                                                                    reconciliationRESOURCES BLOCK Save your seat: Live OB/GYN Global Codes Update Webinar (July 7, 2026, 4:00 PM ET) · eligibility.natrevmd.com/obgyn-global-updates-webinar Book a 1:1 with Dr. Signorelli · calendly.com/heather-natrevmd/ Practice Revenue Leak Scorecard · eligibility.natrevmd.com/nrm-revenue-scorecard-v3 Payment Posting Audit Checklist · eligibility.natrevmd.com/payment-posting-checklist RECOVER Diagnostic Quiz · natrevmd.com/quiz Series Part 3 (EP191): https://podcasts.apple.com/us/podcast/191-labor-management-is-no-longer-invisible/id1624182351?i=1000775009191

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Ravi Bashyal, Vice-Chairman, Patient and Provider Experience and Director, Outpatient Hip and Knee Replacement Surgery, Endeavor Health; Clinical Assistant Professor, Orthopaedic Surgery, University of Chicago Pritzker School of Medicine. He discusses leading through healthcare consolidation, maintaining a relentless focus on patient outcomes and experience, and delivering high-value outpatient joint replacement care in an evolving healthcare landscape.

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Ravi Bashyal, Vice-Chairman, Patient and Provider Experience and Director, Outpatient Hip and Knee Replacement Surgery, Endeavor Health; Clinical Assistant Professor, Orthopaedic Surgery, University of Chicago Pritzker School of Medicine. He discusses leading through healthcare consolidation, maintaining a relentless focus on patient outcomes and experience, and delivering high-value outpatient joint replacement care in an evolving healthcare landscape.

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Ravi Bashyal, Vice-Chairman, Patient and Provider Experience and Director, Outpatient Hip and Knee Replacement Surgery, Endeavor Health; Clinical Assistant Professor, Orthopaedic Surgery, University of Chicago Pritzker School of Medicine. He discusses leading through healthcare consolidation, maintaining a relentless focus on patient outcomes and experience, and delivering high-value outpatient joint replacement care in an evolving healthcare landscape.

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Martin Jenter, Orthopedic Surgeon, Integrowth Orthopedic Specialists and Henry Ford Health System & Medical Director, Michigan Outpatient Surgical Center ASC. He discusses the rapid growth of outpatient joint replacement, the challenges posed by health system consolidation and electronic health records, and how physician-led ambulatory surgery centers can enhance efficiency, patient experience, and clinical outcomes.

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Martin Jenter, Orthopedic Surgeon, Integrowth Orthopedic Specialists and Henry Ford Health System & Medical Director, Michigan Outpatient Surgical Center ASC. He discusses the rapid growth of outpatient joint replacement, the challenges posed by health system consolidation and electronic health records, and how physician-led ambulatory surgery centers can enhance efficiency, patient experience, and clinical outcomes.

This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Dr. Martin Jenter, Orthopedic Surgeon, Integrowth Orthopedic Specialists and Henry Ford Health System & Medical Director, Michigan Outpatient Surgical Center ASC. He discusses the rapid growth of outpatient joint replacement, the challenges posed by health system consolidation and electronic health records, and how physician-led ambulatory surgery centers can enhance efficiency, patient experience, and clinical outcomes.

A Podcast from Obstetrics & Gynecology highlighting the latest research and practice updates in the field. This episode features an interview with Dr. Ingmar N. Bastian, author of "Evaluation of Postpartum Glucose Tolerance Test Results Based on Criteria and Timing," and Dr. Ashley Battarbee, author of the accompanying editorial, "Reimagining Postpartum Diabetes Screening: From Immediate Oral Glucose Tolerance Testing to Innovative Strategies."

Today's guest is Jessica Vaughn, DNP, RN, NEA-BC, CCDS, CCDS-O, CRC, CDI education specialist for ACDIS and HCPro. Our intro and outro music for the ACDIS Podcast is “medianoche” by Dee Yan-Kay and our ad music is “Take Me Higher” by Jahzzar, both obtained from the Free Music Archive. Have questions about today's show or ideas for a future episode? Contact the ACDIS team at info@acdis.org. Want to submit a question for a future "listener questions" episode? Fill out this brief form!  CEU info: Each ACDIS Podcast episode offers 0.5 ACDIS CEU which can be used toward recertifying your CCDS or CCDS-O credential for those who listen to the show in the first four days from the time of publication. To receive your 0.5 CEU, go to the show page on acdis.org, by clicking on the “ACDIS Podcast” link located under the “Free Resources” tab. To take the evaluation, click the most recent episode from the list on the podcast homepage, view the podcast recording at the bottom of that show page, and click the live link at the very end after the music has ended. Your certificate will be automatically emailed to you upon submitting the brief evaluation. (Note: If you are listening via a podcast app, click this link to go directly to the show page on acdis.org: https://acdis.org/acdis-podcast/outpatient-cdi-retrospective-reviews) Note: To ensure your certificate reaches you and does not get trapped in your organization's spam filters, please use a personal email address when completing the CEU evaluation form. The cut-off for today's episode CEU is Sunday, June 21, at 11:00 p.m. Eastern. After that point, the CEU period will close, and you will not be eligible for the 0.5 CEU for this week's episode. ACDIS update: Respond to the 2026 CDI Week Industry Survey by July 6! (https://www.surveymonkey.com/r/2026-CDI-Week-Industry-Survey)

At ACDIS 2026 I delivered an unofficial episode of Off the Record with my guest today: Tracy Ferro, Executive Director, System CDI for Medical University of South Carolina Health (MUSC). The “podcast” was delivered on stage, at the outpatient symposium. MUSC's OP CDI program is new and being built in flight, and Tracy and I presented on it together, running the session a bit like an episode of #OTR. Full disclosure: Norwood partnered with MUSC, large academic health system, to implement OP CDI. That was a challenge! As was the Chicago presentation. On today's episode we talk not only about MUSC's OP CDI efforts but the presentation itself, including the prep and leadup and “game day.” And much more on Tracy's unique leadership style and the importance of storytelling to drive home lessons (she's wonderful at this). Listen in as we discuss: Tracy's healthcare background, a memorable nursing experience, and path into CDI. The art of leadership: Style and lessons learned from childhood and beyond MUSC's outpatient CDI origins: The why behind the program What a pre-visit review looks like, including the use of Epic's Enhanced Risk Adjustment Framework. Governance, workflows, reporting, and early outcomes. Outpatient CDI impact and next steps for the new program Presenting at ACDIS 2026, including tips on prep and combatting stage nerves An unexpected Sharpie arm signature and a song for the OTR Spotify playlist...

Episode 206. Join me for a behind-the-scenes look at a typical day in outpatient psychiatry as a resident, with some honest, mini-rants about note-writing and medications vs. psychotherapy. I also discuss my strategies for maintaining work-life balance and give advice for medical students applying to residency.Learn more about the Medical Student CV Masterclass: ⁠https://www.firstlinepodcast.com/courseAccess the exclusive MCAT Cram Session Series: Subscribe to First Line on Spotify creators.spotify.com/pod/profile/firstline/subscribeEditing Service for Pre-Med and Medical Students (CV, personal statement, applications): https://www.firstlinepodcast.com/servicesFor a discount on your TrueLearn USMLE or COMLEX subscription go to ⁠https://truelearn.referralrock.com/l/firstline/⁠ and use the code firstline at checkoutContent on First Line is for educational and informational purposes only and not intended to be used as medical advice. Views expressed are my own and do not represent any organizations I am associated with.

This podcast describes a research project at an academic health system to pilot an outpatient pharmacy continuous glucose monitoring service. Listeners will learn about the process of developing and implementing a continuous glucose monitoring service within an outpatient pharmacy setting.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Elad I. Levy, MD, MBA, FCNS is a Neurosurgeon at Atlas Surgical Center and Chair of Neurosurgery at the University at Buffalo and Director of Neurosciences at Kaleida Health, discusses the creation of the nation's first Ambulatory Neurosurgery Center and the opportunities it creates for patient access, cost reduction, and clinician well-being.

In this episode, Elad I. Levy, MD, MBA, FCNS is a Neurosurgeon at Atlas Surgical Center and Chair of Neurosurgery at the University at Buffalo and Director of Neurosciences at Kaleida Health, discusses the creation of the nation's first Ambulatory Neurosurgery Center and the opportunities it creates for patient access, cost reduction, and clinician well-being.

Hear two post-fracture care specialists share their perspective on how to effectively transition patients' post-fracture osteoporosis care from the inpatient to outpatient setting. Dr. Aloiya Kremer will share her perspective on best practices for starting a post-fracture osteoporosis care program, while Jacqi Kernaghan will discuss what she has learned about the inpatient to outpatient integration from her work in a specialized osteoporosis clinic. Listeners will gain valuable insights into how to effectively manage patients after they leave the hospital to minimize the risk of subsequent fractures. Dr. Kremer and Ms. Kernaghan are paid consultants for Amgen.This episode is sponsored by Amgen.

Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series Journal of Addiction Medicine Initiating weekly long-acting injectable buprenorphine (LAIB) without prior sublingual buprenorphine (“direct-to-inject” or DTI) may reduce buprenorphine initiation barriers. In this case series, outpatient DTI outcomes are described. Of the 23 patients with available data, 19 (83%) had no withdrawal symptoms pre-DTI. Of the 20 patients with documented post-DTI withdrawal symptoms, 3 (15%) had no withdrawal, 12 (60%) had mild, 4 (20%) had moderate, and one (5%) patient had severe withdrawal. Thirty days post-DTI, 14 (58%) patients were retained on any buprenorphine formulation, and 11 (46%) patients were retained at 90 days. The median post-DTI buprenorphine treatment days were 77 (range: 9–90).  The majority of patients had no pre-DTI withdrawal symptoms, no or mild withdrawal symptoms post-DTI, and were retained on buprenorphine at 30 days post-DTI, with nearly half retained at 90 days. DTI is a promising buprenorphine initiation strategy, but further research is warranted.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

“My doctor says it's safe, but Google says it's not… what do I do?” It's the reality so many pregnant and breastfeeding moms face when they're given conflicting medication advice.  In this episode, consulting pharmacist Dr. Danielle Plummer and clinical pharmacist Dr. Tara Birch pull back the curtain on pregnancy medication confusion and why it happens. As Tara puts it, “Pharmacists need to be utilized more than they are. We are medication specialists.”  The core message is clear: every mom needs a pharmacist as part of her care team. From preconception through the postpartum period, pharmacists bring the medication expertise that is often missing and can prevent confusion, errors, and unnecessary risk. From the overwhelm of choosing a prenatal vitamin to navigating mixed messages from providers and “Dr. Google,” they walk through what's actually happening behind the scenes and how to make safer, more confident decisions. You'll hear why “there is no one-size-fits-all prenatal vitamin,” how postpartum needs can increase during breastfeeding, and why a truly collaborative care team leads to better outcomes for both mom and baby. If you've ever second-guessed a medication, felt confused by conflicting advice, or wished you had a clear, trusted voice guiding you, this conversation will change how you approach your care. What You'll Learn: - Why pharmacists are underused in maternal care - How to handle conflicting medication advice - How to choose the right prenatal vitamin - Why postpartum nutrition matters - The risks of relying on Google or AI for medication decisions - How collaborative care improves outcomes Expert Insights: - Pharmacists in Maternal Care: Pharmacists are medication experts but are often excluded from care teams. Including them improves safety and outcomes. - Conflicting Advice: Patients often receive mixed guidance from providers. Pharmacists help clarify evidence-based decisions. - Prenatal Vitamins: Not one-size-fits-all. Needs vary by diet, genetics, and symptoms. - Postpartum Nutrition: Nutrient needs may increase after delivery, especially during breastfeeding. - Gaps in Care: Hospital care is collaborative. Outpatient care is fragmented, creating safety risks. - Preconception Planning: Medication review before pregnancy can prevent first-trimester risks. Connect with Dr. Tara Birch: https://themotherbabypharmacist.com www.instagram.com/themotherbabypharmacist/ Phone/Text: 321-609-5424 Connect with Dr. Danielle Plummer: www.HGPharmacist.com linkedin.com/in/daniellerplummer

Virtual supervision is reshaping outpatient radiology — helping imaging centers cut costs, extend hours, and meet the new C M S permanent ruling on remote contrast oversight. Learn how real-world facilities are making it work. Learn more at https://www.contrast-connect.com/ ContrastConnect City: Las Vegas Address: Las vegas Website: https://www.contrast-connect.com/

Dr. Shelby Blankenship PT, DPT discusses a case study on a post ICU deconditioned patient due to cervical spine surgery complications. The episode covers assessment, treatment approach, progression, outcomes, and takeaways for similar cases. Want to make sure you stay on top of all things geriatrics? Go to https://MMOA.online to check out our Free eBooks, Lectures, & the MMOA Digest!

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UKJ865. CME/NCPD/AAPA credit will be available until April 10, 2027.ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UKJ865. CME/NCPD/AAPA credit will be available until April 10, 2027.ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UKJ865. CME/NCPD/AAPA credit will be available until April 10, 2027.ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UKJ865. CME/NCPD/AAPA credit will be available until April 10, 2027.ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UKJ865. CME/NCPD/AAPA credit will be available until April 10, 2027.ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Bristol Myers Squibb, Caribou Biosciences, Inc., Kite, A Gilead Company, Miltenyi Biomedicine, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

What does it take to bring innovative embolization procedures like prostate artery embolization (PAE) and genicular artery embolization (GAE) into the outpatient setting? Dr. Kavi Devulapalli and Dr. Jerry Niedzwiecki share their experiences pioneering these treatments in office-based labs (OBLs), highlighting the clinical benefits, patient selection strategies, and workflow efficiencies that come with outpatient care. The conversation dives into real-world challenges, including reimbursement hurdles and the importance of advocacy and data collection through societies like OEIS. Gain practical insights on responsible practice, collaboration, and how building robust clinical evidence is key to advancing the field and securing patient access.

In this episode, Wake Radiology's President and Managing Partner Brent Townsend, MD and COO Parul Galloway discuss practical strategies to help mitigate patient access, workforce and other common challenges to successfully scale outpatient imaging. Together with Jason Weshler, VP of Outpatient Solutions at Siemens Healthineers, they explore how digitalization and AI-based tools, operational innovations, and advocacy efforts are shaping the future of patient-centered radiology care.This episode is sponsored by Siemens Healthineers.

In this episode, Wake Radiology's President and Managing Partner Brent Townsend, MD and COO Parul Galloway discuss practical strategies to help mitigate patient access, workforce and other common challenges to successfully scale outpatient imaging. Together with Jason Weshler, VP of Outpatient Solutions at Siemens Healthineers, they explore how digitalization and AI-based tools, operational innovations, and advocacy efforts are shaping the future of patient-centered radiology care.This episode is sponsored by Siemens Healthineers.

As federal oversight of risk adjustment and documentation practices intensifies, healthcare organizations are facing new scrutiny regarding how patient complexity is documented and reported. Recent guidance and enforcement activity from the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has placed renewed focus on risk-adjustment accuracy, defensible documentation, and compliance across both Medicare Advantage (MA) and value-based payment models. During the next episode of Talk Ten Tuesday, Jason Jobes, a CDI expert, will discuss why outpatient clinical documentation integrity (CDI) programs are becoming increasingly important in this environment. He will explore how documentation practices, provider education, and governance strategies can help organizations accurately capture patient complexity while reducing audit exposure and protecting revenue.The popular weekly Internet broadcast will also feature these additional instantly recognizable panelists, who will report more news during their segments:·      POV: Penny Jefferson, Manager of Coding & Clinical Documentation Integrity Services for the University of California-Davis Medical Center, will share her point of view during the broadcast.·      CDI Report: Cheryl Ericson will provide an update on all things CDI.·      The Coding Report: Christine Geiger will report on the latest coding news.·      News Desk: Timothy Powell, ICD10monitor national correspondent, will anchor the Talk Ten Tuesdays News Desk.

In this week's episode, Rex Nelson talks with a psychiatrist at the UAMS women's mental health clinic, Dr. Jessica Coker and the UAMS outpatient director of the women's mental health program, Dr. Shona Ray-Griffith, about women's mental health in Arkansas. Coker and Ray-Griffith talk about pregnancy planning, maternal mental health and postpartum mental health and how it impacts women in Arkansas. Podcast on Apple, Spotify, and YouTube, or visit arkansasonline.com/podcast23 for an exclusive subscription offer available only to podcast listeners Chapters (00:00:13) - Southern Fried Podcast(00:01:01) - The Women's Mental Health Program at UAMS(00:04:55) - Postpartum depression: Outpatient and inpatient care(00:07:58) - Mental health care: Between psychiatry and therapy(00:11:44) - Are Our Medications Safe During Pregnancy?(00:14:07) - How to manage mental health during pregnancy and postpartum?(00:15:49) - How to cope with pregnancy blues(00:18:07) - Should You Seek Mental Health Help after Having a Baby?(00:22:37) - UAMS Health System: A Big Picture(00:23:35) - UAMS doctor on access to care in Arkansas

Cardiology is shifting from inpatient to outpatient care. In this MedAxiom HeartTalk, host Melanie Lawson, MS, talks with Amy Brownell, MSN, FNP-C, FACC, cardiovascular service line director at Ascension Illinois Market about strategies for expanding ASCs and office-based labs while maintaining clinical quality. They also discuss operational and financial considerations that help health systems thrive in this changing landscape.

In this episode of The ASHE Podcast, hosts Dr. Gonzalo Bearman and Dr. Priya Nori sit down with Dr. Lindsey Childs-Kean and Dr. Alexandra Yamshchikov to discuss their recent publication highlighting a curated bundle of the top 10 OPAT-related studies from 2024. Outpatient parenteral antimicrobial therapy (OPAT) remains a cornerstone of infectious diseases practice, with a growing body of research shaping how clinicians deliver safe and effective care outside the hospital setting. In this conversation, the authors break down the most clinically impactful OPAT publications of the year, offering key insights, emerging trends, and practical takeaways for providers. https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/bundle-of-the-top-10-opat-publications-in-2024/F22DABCC50AED0A66CA53840508B8BD8#article

Dr. Centor discusses hyponatremia in the outpatient setting with Dr. Joel Topf.

What does it look like when an early-career clinician steps up to solve real barriers patients face — not just their pain?Wisconsin-based PT and Fellow-in-Training Rachel Beilfuss joins us to talk about her mission to integrate social determinants of health (SDoH) into everyday outpatient PT practice. As a Northwestern OMPT fellow with a clinical site at Marquette University, she's building systems to help clinicians screen, identify, and address the life factors that shape recovery and access.Rachel is also this year's FOMPT scholarship recipient, representing the next generation of OMPT clinicians who are redefining what comprehensive care looks like.In this episode, we dig into:???? Why SDoH screening belongs in musculoskeletal care???? How Rachel is building clinic workflows + resource guides???? Her experience as a Fellow-in-Training at Northwestern/Marquette???? The importance of advocating for patients' basic needs???? What early-career leadership looks like in AAOMPT???? How lifestyle, access, and equity affect rehab outcomes???? Why clinicians need support beyond biomechanics to serve patients fullyThis one is full of passion, practicality, and vision from one of the profession's rising voices.

In this episode of Between the Lines with FGI, hosts Marissa Lamperis Kastrinos and John Williams sit down with the tri‑chairs of the 2026 FGI Codes for Planning and Design of Outpatient Settings: Kevin Matuszewski, Collin Beers, and Jennifer Kuschinsky. Together, they explore the major updates shaping the 2026 FGI Outpatient Code and discuss how evolving clinical practices, advancing technology, and new models of care are transforming outpatient environments. The conversation also offers a behind-the-scenes look at the multiyear revision process and the collaboration that drives the development of the FGI Codes. Listeners will get an inside look at new chapters, clarified terminology, streamlined imaging requirements, and the growing role of flexible, multifunctional outpatient spaces designed to support the future of care.    Sponsored by: American Society for Health Care Engineering (ASHE): Optimizing health care facilities    Link to show notes: https://fgiguidelines.org/podcast/s3-e4-the-code-ahead-a-preview-to-the-2026-fgi-outpatient-code/   Take a deeper dive into the 2026 FGI Outpatient Code: An on-demand webinar is available at FGI University that breaks down the specific updates mentioned in this episode, plus additional context and practical takeaways, directly from the chairs of the Outpatient Document Group of the 2026 Health Guidelines Revision Committee (HGRC).    Earn CEUs Anytime with FGI University and Between the Lines with FGI:  Gain even more insight with the extended version of this episode while earning continuing education units (CEUs)! Head over to FGIUniversity.org our educational platform for the FGI Codes/Guidelines, and explore CEU- and HSW-approved audio courses designed to make earning credits effortless—perfect for learning on the go.   To make it even better, use promo code BTL10 at checkout to get 10% off any Between the Lines with FGI course and the on-demand webinar for the 2026 FGI Outpatient Code. Listen, learn, and save today.    AIA self-reporting: FGI is a registered provider of AIA-approved continuing education under Provider Number 38744124. All registered AIA CES Providers must comply with the AIA Standards for Continuing Education Programs. Any questions or concerns about this provider or this learning program may be sent to AIA CES (cessupport@aia.org). This learning program may be self-reported for LU credit through the AIA Continuing Education System. As such, it does not include content that may be deemed or construed to be an approval or endorsement by the AIA.  To receive AIA self-reported LUs, learners must complete and self-report two of these entire learning programs for 1 LU.  Learn more about AIA self-reporting LUs: https://fgiguidelines.org/aia-self-reporting-lus/  Connect with us on LinkedIn Author: Facility Guidelines Institute 

Dr. Erdei is a triple board certified physician (neonatology, pediatrics, and developmental-behavioral pediatrics!) who talks us through high risk infant clinic! There is no one-size-fits-all approach to NICU follow-up, so Dr. Erdei draws on her years of experience to share the set-up of her own clinic. We talk about common challenges like evaluating adequate growth, preterm formulas/fortifiers, feeding intolerance, neurodevelopmental assessments and her expert advice for helping babies thrive in their family unit once they go home!

A major change in outpatient cardiac care is underway. On this MedAxiom HeartTalk, host Melanie Lawson, MS sits down with David Kenigsberg, MD, FACC, FHRS, a clinical cardiac electrophysiologist based in Northern Broward County, Florida. Together, they unpack the shift toward performing ablation procedures in ambulatory surgical centers (ASCs) — why it's happening, how it improves patient access and cost-effectiveness.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472 Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes. Episode resource links: Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., & Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association. Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., & Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.   Balasubramanian, I., Andres, E. B., & Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272. Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472 Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes. Episode resource links: Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., & Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association. Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., & Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.   Balasubramanian, I., Andres, E. B., & Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272. Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

How can patients receive more consistent interventional radiology care amid a national shortage of IR physicians? That question led Dr. Rick Daniels to develop a new outpatient practice model centered on recruiting independent IRs to provide long-term, fractional coverage for groups in need. In this episode of the BackTable Podcast hosted by Dr. Aaron Fritts, Dr. Daniels outlines the thinking behind this approach and how it aims to expand access to IR services in outpatient settings. --- SYNPOSIS The conversation examines the evolving landscape of IR practice, including the challenges associated with transitioning between practice settings and building sustainable outpatient service lines. Dr. Daniels walks through the development of his model, with particular attention to identifying and supporting outpatient embolization opportunities. The discussion also explores the consortium-style structure for independent IRs, emphasizing long-term alignment, professional autonomy, and scalability at a national level. Operational considerations such as technology partnerships, documentation workflows, and targeted marketing strategies offer a practical look at what it takes to make this model work. --- TIMESTAMPS 00:00 - Introduction03:49 - Evolution of an Independent IR Practice05:30 - Challenges and Opportunities in Outpatient IR09:58 - Building Service Lines and Marketing Strategies18:34 - Forming a National IR Group25:21 - Balancing Business and Healthcare25:37 - Evaluating and Correcting Site Performance28:16 - Expanding Geographical Reach30:45 - Recruitment and Retention Challenges38:07 - The Importance of Tech-Doc Teams42:35 - Future Goals and Recruitment Efforts45:58 - Conclusion

In this episode, Robert C. Rhoad, MD, Partner at OrthoCincy Orthopaedics & Sports Medicine, Hand, Wrist & Elbow Orthopaedic Surgery, shares how orthopedic care is shifting to outpatient, ASC, and office based settings. He discusses staying independent, expanding walk in and in office procedures, and the collaborations helping physician led groups innovate while preserving autonomy.

In this episode, Robert C. Rhoad, MD, Partner at OrthoCincy Orthopaedics & Sports Medicine, Hand, Wrist & Elbow Orthopaedic Surgery, shares how orthopedic care is shifting to outpatient, ASC, and office based settings. He discusses staying independent, expanding walk in and in office procedures, and the collaborations helping physician led groups innovate while preserving autonomy.

In this episode, Allison Roditi, Vice President of Orthopedics at Catholic Health, shares how the system is unifying employed and independent physicians, preparing for rapid outpatient growth, and navigating CMS policy changes. She discusses regional strategy, standardizing care and education, and building resilient orthopedic service lines centered on access, quality, and patient experience.

In this episode, Allison Roditi, Vice President of Orthopedics at Catholic Health, shares how the system is unifying employed and independent physicians, preparing for rapid outpatient growth, and navigating CMS policy changes. She discusses regional strategy, standardizing care and education, and building resilient orthopedic service lines centered on access, quality, and patient experience.

CardioNerds (Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Natalie Marrero) discuss anti-arrhythmic drugs in the management of atrial fibrillation and atrial flutter with electrophysiologist Dr. Andrew Epstein. We discuss two major classes of anti-arrhythmic drugs, class IC and class III, as well as digoxin. Dr. Epstein explains their mechanisms of action, indications and specific patient populations in which they would be particularly helpful, efficacy, adverse side effects, contraindications, and key drug-drug interactions. We also elaborate on defining clinical trials and their clinical implications. Given the large burden of atrial fibrillation and atrial flutter in our patient population and the high prevalence of anti-arrhythmic drug use, this episode is sure to be applicable to many practicing physicians and trainees. Audio editing by CardioNerds academy intern, Grace Qiu.  Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Anti-arrhythmic drugs should not be thought of as an alternative to ablation but, instead, should be considered an adjunct to catheter ablation.   Class IC anti-arrhythmic drugs, flecainide and propafenone, are highly efficacious for acute cardioversion and a great option for patients with infrequent episodes of AF who do not have a history of ischemic heart disease.    Class III anti-arrhythmic drugs like ibutilide, sotalol, and dofetilide, are highly effective for acute conversion; however, they require hospitalization for close monitoring during initiation and dose titration given the risk of prolonged QT.   Amiodarone should not be used as a first line agent given its toxicities, prolonged half-life, large volume of distribution, and drug-drug interactions.   Dr. Epstein notes that, “All drugs are poisons with a few beneficial side effects,” when highlighting the many adverse side effects of anti-arrhythmic drugs, particularly amiodarone, and the importance of balancing their benefit in rhythm control with their side effect profile.   Notes Notes: Notes drafted by Dr. Natalie Marrero. What are the Class IC anti-arrhythmic drugs and what indications exist for their use?   Class IC anti-arrhythmic drugs are anti-arrhythmic drugs that work by blocking sodium channels and, thereby, prolonging depolarizing.   Class IC anti-arrhythmic drugs include flecainide and propafenone.   Class IC anti-arrhythmic drugs are good agents to use in patients that have infrequent episodes of AF and do not want daily dosing as these agents can be used by patients when they feel palpitations and desire acute conversion back to sinus rhythm (“pill in the pocket” approach).    What are the adverse consequences and/or contraindications to using a class IC agent?  Class IC anti-arrhythmic agents are contraindicated in patients with a history of ischemic heart disease based on increased mortality associated with their use in these patients in the CAST trial.   Given the results of the CAST trial, providers should screen annually for ischemia via a functional stress test in patients on these drugs at risk for coronary disease.   These drugs can increase 1:1 conduction of atrial flutter and, therefore, require concomitant use of a beta blocker.   These agents are generally well-tolerated without any organ toxicities; however, they can precipitate heart failure in patients with cardiomyopathies, cause sinus node depression, and unmask genetic arrythmias such as a Brugada pattern.   What are the class III agents and what are indications for their use?   Class III agents are drugs that block the potassium channel, prolonging the QT, and include Ibutilide, Sotalol, and Dofetilide.    Class III agents can be considered in patients with or without a history of ischemic heart disease that desire effective acute chemical cardioversion and are willing to go to the hospital for close monitoring during dose initiation and titration.   Other specific circumstances in which one can use these agents, specifically Ibutilide, are in patients with recurrent atrial fibrillation and Wolf Parkinson White (due to slowed conduction via the accessory pathway).  What are the adverse consequences and/or contraindications to using a class III agent?  Ibutilide, Sotalol, and Dofetilide prolong the QT and increase the risk of torsade de pointes, which is why they require ECG monitoring in-patient during drug initiation and dose titration.    These agents are generally well-tolerated.   Sotalol should be avoided or used cautiously in patients with left ventricular dysfunction, while dofetilide can be used and has dose-response beneficial effects in patients with left ventricular dysfunction.   Both sotalol and dofetilide are renally cleared with specific creatinine clearance cutoffs (CrCl < 20 for dofetilide and CrCl